PHARMACEUTICAL COMPOSITION FOR ANTIVIRUS COMPRISING BASE, NUCLEOSIDE OR NUCLEOTIDE, AS ACTIVE COMPONENT

• 收藏
• 分享

专利权人:

KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY;한국생명공학연구원

发明人:

KWON, DUR HAN,권두한,SONG, JAE HYUNG,송재형,OH, SEI RYANG,오세량,LEE, HYEONG KYU,이형규,EUKHTAIVAN GANSUKH,행흐테왕, 강수흐

申请号：

KR1020110122550

公开号：

KR1020130056784A

申请日:

2011.11.22

申请国别(地区):

KR

年份:

2013

代理人:

摘要：

PURPOSE: A base, a nucleoside, or a nucleotide effectively is provided to suppress virus replication with less side effects and to be used as an antiviral pharmaceutical composition. CONSTITUTION: An antiviral pharmaceutical composition contains one or more selected from the group consisting of adenine, guanine, uracil, cytosine, adenosine, guanosine, uridine, cytidine, adenosine biphosphate, and adenosine triphosphate. Rhinovirus is selected among rhinovirus type 2, 3, 14, 15, and 40. Enterovirus is enterovirus type 71. A pharmaceutical composition for anti-influenza virus contains adenosine and/or adenine as active ingredients. The influenza virus is influenza virus type A.본 발명은 부작용이 적고, 많은 아형을 가지는 라이노바이러스, 엔테로바이러스 또는 인플루엔자 바이러스와 같은 바이러스에 대하여, 효과적인 바이러스 증식 억제활성을 가지는 염기, 뉴클레오사이드, 또는 뉴클레오타이드에 관한 것이다.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/